.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Dow
Mallinckrodt
Accenture
Federal Trade Commission
Healthtrust
McKinsey
US Department of Justice
Johnson and Johnson

Generated: June 28, 2017

DrugPatentWatch Database Preview

DAYPRO Drug Profile

« Back to Dashboard

What is the patent landscape for Daypro, and when can generic versions of Daypro launch?

Daypro is a drug marketed by Gd Searle and is included in two NDAs.

The generic ingredient in DAYPRO is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.

Summary for Tradename: DAYPRO

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list65
Clinical Trials: see list2
Patent Applications: see list6,887
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DAYPRO at DailyMed

Pharmacology for Tradename: DAYPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle
DAYPRO
oxaprozin
TABLET;ORAL018841-004Oct 29, 1992ABRXYesYes► Subscribe► Subscribe
Gd Searle
DAYPRO ALTA
oxaprozin potassium
TABLET;ORAL020776-001Oct 17, 2002DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Queensland Health
Boehringer Ingelheim
Mallinckrodt
McKinsey
Deloitte
Merck
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot